About Us
About SANXI
Sanxi Sponge started in 1999. Headquartered in China, we are a world-leading specialist in polyurethane foam technologies employing over 300 people in 4 manufacturing and R&D centers.
Manufacturing Centers
Employees
Export Countries
Company establishment
Professional Expertise
Thirty years of research, development, and manufacturing experience, with deep specialization in the polyurethane sponge.
Innovation-Driven
Proficient in raw material modification, capable of quickly grasping the latest market demands.
Differentiated Value
Creates value for customers through product and solution differentiation.
Service Commitment
Upholds consistent quality and professional service, providing reliable support to clients.
Products
Polyurethane Foam Manufacturing Expert
News
View the Latest News in the Polyurethane Industry
2026-06-16
Sanxi Medical: Riding the Waves and Going Global
In today’s era of relentless globalization, a growing number of Chinese enterprises are boldly stepping onto the world stage, showcasing the robust strength of “Made in China.” Qingdao Sanxi Medical Supplies Co., Ltd. is a steadfast pioneer in this endeavor. With its outstanding technological prowess and professional product‑service offerings, Sanxi Medical has earned high acclaim from international customers. This represents not only one successful market expansion after another, but also serves as a shining “Chinese calling card” on the global stage.
Qingdao Sanxi Medical Products Co., Ltd
Over the past months, our team has undertaken countless market studies, refined our proposals, and engaged in late-night discussions. Starting from a modest idea, we have steadily transformed it into a comprehensive business plan—and now into this state-of-the-art medical workshop. Today, December 18, 2025, Qingdao Sanxi Medical Supplies Co., Ltd. officially launches, marking not an end, but the first step on a long and arduous journey.
The Brave Sailor Sailing Against the Wind – Sanxi
During the three-year pandemic winter—marked by global supply-chain disruptions, flight‑cancellation policies, and the suspension of in‑person trade shows—while most companies opted to hunker down and wait-and-see, a cohort of Chinese enterprises resolutely pivoted and set out for overseas markets.